Project Grant R21DA062844
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $237K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30303, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- This federal Project Grant award, titled "Functions and Mechanisms of CRYM-Positive Astrocytes in the Nucleus Accumbens", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $134,556 award, effective June 24, 2025 through December 31, 2027, supports research by the University of California, Los Angeles (UCLA) to elucidate the functions of a specific subpopulation of astrocytes within the nucleus accumbens and...
- This federal Project Grant award of $121,323.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will support research by the University of North Carolina at Chapel Hill to investigate the structural and functional responses of nucleus accumbens microglia following long-access cocaine self-administration. The research aims to elucidate the role of microglia and...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $180,646 to the Icahn School of Medicine at Mount Sinai to investigate the molecular mechanisms by which astrocytic CREB regulation influences cocaine addiction-related behavior. The research aims to elucidate the underlying transcriptional and epigenetic regulation of astrocytes in the context of drug abuse and addiction. Key activities...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,351,034 to the University of Alabama at Birmingham (UAB) to study the role of somatostatin-expressing interneurons in the prelimbic region of the rodent medial prefrontal cortex and their involvement in natural and drug reward seeking behaviors. The award, with a project period from Apr 15, 2025...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to examine the relationship between neighborhood conditions, neural circuits, and substance use behaviors across the early life course. The $2,314,254 award to The Research Foundation For The State University Of New York, doing business as Suny Downstate Health Sciences University, will fund a longitudinal study to investigate...
- This federal Project Grant award of $613,786.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting research to elucidate the molecular, cellular, and physiological consequences of D1 dopamine receptor (D1DR) signaling from both the plasma membrane and Golgi compartments in primary medium spiny neurons. The research aims to advance understanding of the role of compartmentalized D1DR signaling in the neurobiology...
- This federal Project Grant award of $623,650 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant is funding research at Oregon Health & Science University to investigate how adolescent social isolation and disruption of thyroid hormone signaling in the basolateral amygdala may contribute to substance use disorder vulnerability. The project aims to elucidate the...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...